Bionano Genomics BNGO
NASDAQ BNGO
$1.16 +0.01 (+0.87%)
At close: Nov 9, 2026 · 4:00 PM EST

Bionano Genomics (BNGO) Non-Current Deferred Revenue (2017 - 2026)

Updated

Bionano Genomics (BNGO) posted Non-Current Deferred Revenue of $118,000 for Q2 2026, down 51.4% from $243,000 a year earlier and down 17.5% from the prior quarter.

Analysis

Bionano Genomics (BNGO) Non-Current Deferred Revenue (2017 - 2026) Analysis & Trends

At the end of FY2025, Bionano Genomics' Non-Current Deferred Revenue came in at $249,000, down 6.7% from FY2024.

  • Annual Non-Current Deferred Revenue shows a five-year compound annual growth rate of 20.5% (FY2020 to FY2025).
  • In prior years, Bionano Genomics' Non-Current Deferred Revenue was $267,000 in FY2024 (+73.4%), $154,000 in FY2023 (+21.3%), $127,000 in FY2022 (-13.0%) and $146,000 in FY2021 (+49.0%).
  • The Q2 2026 figure stands as the lowest quarterly Non-Current Deferred Revenue since Q1 2021.
  • On a year-over-year basis, Non-Current Deferred Revenue has declined in each of the last five quarters, with growth averaging 14.0% over the last eight quarters.
  • The strongest year-over-year quarter for Non-Current Deferred Revenue in the past five years was Q1 2025, with growth of 111.6%; the weakest was Q2 2026, with a decline of 51.4%.
  • According to Business Quant data, Non-Current Deferred Revenue for the three prior quarters was $143,000 (Q1 2026), $249,000 (Q4 2025) and $192,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 267.71 Bn 244.23 Bn 5.13 Bn
2 Abbott Laboratories 191.69 Bn 165.56 Bn 7.39 Bn
3 Danaher 166.18 Bn 145.83 Bn 3.84 Bn
4 Intuitive Surgical 161.07 Bn 141.36 Bn 2.08 Bn
5 Medtronic 131.65 Bn 96.90 Bn 6.34 Bn
6 Stryker 125.25 Bn 111.44 Bn 4.25 Bn
7 Boston Scientific 63.85 Bn 59.29 Bn 3.43 Bn
8 Edwards Lifesciences 60.52 Bn 43.72 Bn 1.35 Bn
9 Becton Dickinson 59.08 Bn 56.23 Bn 2.32 Bn
10 Bionano Genomics 13.51 Mn -51.73 Mn 4.31 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 118,000.00
Mar 31, 2026 143,000.00
Dec 31, 2025 249,000.00
Sep 30, 2025 192,000.00
Jun 30, 2025 243,000.00
Mar 31, 2025 292,000.00
Dec 31, 2024 267,000.00
Sep 30, 2024 263,000.00
Jun 30, 2024 272,000.00
Mar 31, 2024 138,000.00
Dec 31, 2023 154,000.00
Sep 30, 2023 151,000.00
Jun 30, 2023 186,000.00
Mar 31, 2023 194,000.00
Dec 31, 2022 127,000.00
Sep 30, 2022 136,000.00
Jun 30, 2022 203,000.00
Mar 31, 2022 133,000.00
Dec 31, 2021 146,000.00
Sep 30, 2021 158,000.00
API Access

Bionano Genomics Non-Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=BNGO&period=max&api_key=YOUR_API_KEY